Skip to main content
$0.120 0.010 (9.09%)

High

$0.12

Low

$0.11

Trades

74

Turnover

$139,612

Volume

1,216,523
30 June 2023 at 4:10pm
If you were already registered, log in here.

Short Interest

ASIC data, 23 Oct 2026

% Shorted

0.00% 4.39
vs 4.39% prior report

Most Shorted Rank

698th
of 717 shorted ASX stocks

Peak Short

4.43%
Dec 2025

Days to Cover

0.0
at 50d avg vol
Subject
CAN Ann: Share Purchase Plan - offer opens

CAN Ann: Cleansing Statement - Share Purchase Plan

CAN Ann: Appendix 3H - Notification of Cessation of Securities

CAN Ann: Application for quotation of securities - CAN

CAN Ann: Amended Quarterly Activities Report

CAN Ann: Quarterly Activities and Appendix 4C Cashflow Report

CAN Ann: Initial Director's Interest Notice - Dr Julian Chick

CAN Ann: Results of Annual General Meeting

CAN Ann: AGM presentation slides

CAN Ann: Chairman's and CEO's Addresses to Shareholders

CAN Ann: Share Purchase Plan

CAN Ann: Proposed issue of securities - CAN

CAN Ann: Cann receives $4.348m in R&D Tax incentive rebate

CAN Ann: Chief Executive Officer role update

CAN Ann: Clinical trial recruitment target met

CAN Ann: Scope of Mildura GMP licence extended

CAN Ann: Resignation and appointment of Company Secretary

CAN Ann: Change of address - corporate and registered office

CAN Ann: Appendix 3Y - Douglas Rathbone

CAN Ann: Notice of Annual General Meeting

CAN Ann: Initial Director's Interest Notice - Mr Robert Barnes

CAN Ann: Mr Robert Barnes & Dr Julian Chick appointed to the Board

CAN Ann: Final Director's Interest Notice

CAN Ann: Resignation of director

CAN Ann: Notice of date of AGM and other relevant dates

CAN Ann: Investor presentation - FY22 Results

CAN Ann: Appendix 4G & Corporate Governance Statement

CAN Ann: Cann releases FY22 results

CAN Ann: Appendix 4E & Annual Report to shareholders - FY22

CAN Ann: Upcoming investor presentation

CAN Ann: Quarterly Activities/Appendix 4C Cash Flow Report

CAN Ann: Leasing facility secured from National Australia Bank

CAN Ann: GMP manufacturing licence granted for Mildura

CAN Ann: Cleansing notice regarding recent issues of shares

CAN Ann: Application for quotation of securities - CAN

CAN Ann: Proposed issue of securities - CAN

CAN Ann: Notification of cessation of securities - CAN

CAN Ann: Application for quotation of securities - CAN

CAN Ann: Notification regarding unquoted securities - CAN

CAN Ann: First commercial crop harvest underway at Mildura facility

CAN Ann: Cann receives payment from Regional Jobs Fund

CAN Ann: Notification regarding unquoted securities - CAN

CAN Ann: Monthly Activities/Appendix 4C Cash Flow Report

CAN Ann: New funding arrangements with National Australia Bank

CAN Ann: Commercial production update

CAN Ann: ODC manufacture permit granted for Mildura

CAN Ann: Evaluation and option agreement with GSK Consumer Healthcare

CAN Ann: Notification of cessation of securities - CAN

CAN Ann: Appendix 3G - lapse of options

CAN Ann: Satipharm CBD products get green light from UK FSA

If you were already registered, log in here.

Similar Companies

CPH
EOF
IHL
MVP
MYX
NEU
PBP
RCE
SPL
S88
MAV
CX8
MTX $12m raise
ATW $7.5m raise
RDO $30m raise
ABC $5m raise
RGS